1
|
Caminiti C, Bryce J, Riva S, Ng D, Diodati F, Iezzi E, Sparavigna L, Novello S, Porta C, Del Mastro L, Procopio G, Cinieri S, Falzetta A, Calabrò F, Lorusso V, Cogoni AA, Tortora G, Maruzzo M, Passalacqua R, Cognetti F, Adamo V, Capelletto E, Ferrari A, Bagnalasta M, Bassi M, Nicelli A, De Persis D, D'Acunti A, Iannelli Patient E, Perrone F, Mitchell SA. Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®). Tumori 2022:3008916221099558. [PMID: 35674125 DOI: 10.1177/03008916221099558] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
INTRODUCTION US National Cancer Institute's (NCI) Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE®) is a library of 78 symptom terms and 124 items enabling patient reporting of symptomatic adverse events in cancer trials. This multicenter study used mixed methods to develop an Italian language version of this widely accepted measure, and describe the content validity and reliability in a diverse sample of Italian-speaking patients. METHODS All PRO-CTCAE items were translated in accordance with international guidelines. Subsequently, the content validity of the PRO-CTCAE-Italian was explored and iteratively refined through cognitive debriefing interviews. Participants (n=96; 52% male; median age 64 years; 26% older adults; 18% lower educational attainment) completed a PRO-CTCAE survey and participated in a semi-structured interview to determine if the translation captured the concepts of the original English language PRO-CTCAE, and to evaluate comprehension, clarity and ease of judgement. Test-retest reliability of the finalized measure was explored in a second sample (n=135). RESULTS Four rounds of cognitive debriefing interviews were conducted. The majority of PRO-CTCAE symptom terms, attributes and associated response choices were well-understood, and respondents found the items easy to judge. To improve comprehension and clarity, the symptom terms for nausea and pain were rephrased and retested in subsequent interview rounds. Test-retest reliability was excellent for 41/49 items (84%); the median intraclass correlation coefficient was 0.83 (range 0.64-0.94). DISCUSSION Results support the semantic, conceptual and pragmatic equivalence of PRO-CTCAE-Italian to the original English version, and provide preliminary descriptive evidence of content validity and reliability.
Collapse
Affiliation(s)
- Caterina Caminiti
- Research and Innovation Unit, University Hospital of Parma, Parma, Italy
| | - Jane Bryce
- Ascension St. John Clinical Research Institute, Tulsa, Oklahoma, USA
| | - Silvia Riva
- Department of Psychology, St Mary's University, London, UK
| | - Diane Ng
- Westat Inc, Rockville, Maryland, USA
| | - Francesca Diodati
- Research and Innovation Unit, University Hospital of Parma, Parma, Italy
| | - Elisa Iezzi
- Research and Innovation Unit, University Hospital of Parma, Parma, Italy
| | - Lucia Sparavigna
- Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli, Italy
| | - Silvia Novello
- Department of Oncology, Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Orbassano, Italy
| | - Camillo Porta
- Division of Medical Oncology, IRCCS San Matteo University Hospital Foundation, Pavia, Italy.,Department of Biomedical Sciences and Human Oncology, University of Bari A. Moro, Bari, Italy
| | - Lucia Del Mastro
- Department of Medical Oncology, IRCCS Azienda Ospedaliera Universitaria San Martino-IST, Genoa, Italy
| | - Giuseppe Procopio
- Fondazione IRCCS, Istituto Nazionale dei Tumori, Oncology Unit 1, Milan, Italy
| | - Saverio Cinieri
- Medical Oncology & Breast Unit, Antonio Perrino Hospital, Brindisi, Italy
| | | | - Fabio Calabrò
- Department of Oncology, San Camillo Forlanini Hospital, Rome, Italy
| | - Vito Lorusso
- Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Oncologico, Bari, Italy
| | | | - Giampaolo Tortora
- Department of Oncology, G.B. Rossi Hospital, University of Verona, Verona, Italy
| | - Marco Maruzzo
- Oncology Unit 1, Istituto Oncologico Veneto IRCCS, Padova, Italy
| | | | - Francesco Cognetti
- Department of Clinical and Molecular Medicine, Università La Sapienza di Roma, Roma, Italy
| | - Vincenzo Adamo
- Medical Oncology Unit, A.O. Papardo & Department of Human Pathology University of Messina, Messina, Italy
| | - Enrica Capelletto
- Department of Oncology, Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Orbassano, Italy
| | - Alessandra Ferrari
- Division of Medical Oncology, IRCCS San Matteo University Hospital Foundation, Pavia, Italy
| | | | | | | | - Davide De Persis
- Federazione Italiana delle Associazioni di Volontariato in Oncologia - F.A.V.O., Rome, Italy
| | - Alessia D'Acunti
- Associazione Italiana Malati di Cancro, parenti ed amici - AIMaC, Rome Italy
| | | | - Francesco Perrone
- Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli, Italy
| | - Sandra A Mitchell
- Division of Cancer Control and Population Sciences, Outcomes Research Branch, National Cancer Institute, Rockville, Maryland, USA
| |
Collapse
|
2
|
Riva S, Maio MD, Efficace F, Frontini L, Gallo C, Giannarelli D, Montesarchio V, De Lorenzo F, Del Campo L, Iannelli E, Traclò F, Gitto L, Jommi C, Vaccaro C, Bryce J, Gimigliano A, Sparavigna L, Perrone F. Measuring financial toxicity of cancer in the Italian health care system: Initial results of the patient reported outcome for fighting financial toxicity of cancer project (proFFiT). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz263.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
3
|
Bryce J, Riva S, Di Maio M, Efficace F, Frontini L, Gallo C, Giannarelli D, Montesarchio V, De Lorenzo F, Del Campo L, Iannelli E, Traclò F, Gitto L, Jommi C, Vaccaro CM, Gimigliano A, Sparavigna L, Perrone F. Measuring financial toxicity of cancer in the Italian health care system: Initial results of the patient reported outcome for fighting financial toxicity of cancer project (proFFiT). J Clin Oncol 2019. [DOI: 10.1200/jco.2019.37.27_suppl.91] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
91 Background: Financial toxicity in cancer patients has been initially reported in the United States and subsequently in other countries, including Italy, despite its health care system is grounded on universal coverage. Considering that the way healthcare and welfare systems are shaped does impact on financial problems faced by cancer patients, we are developing an instrument for evaluating occurrence, gravity, and consequences of financial toxicity in Italy, and hopefully for fighting it. Methods: Concept elicitation, item generation and qualitative analyses represented the initial tasks of the project. Literature review, focus groups with 34 cancer patients or caregivers in three regions located in nothern, central, and southern Italy, and semi-structured interviews with 97 oncologists were conducted for concept elicitation. A recursive process was used to identify themes in the data to inform instrument until saturation was reached. Importance analysis questionnaires were administered to further 44 cancer patients to evaluate and revise the draft item pool. A multi-disciplinary committee (including oncologists, psychologists, statisticians, patient association’s representatives, nurses, social science researchers and economists) oversights the project. Results: Overall, 156 concepts were distributed among 10 themes (bureaucracy, medical care, domestic economy, emotion, family, job, health workers, welfare state, free time, transportation). After controlling for redundancy, 55 candidate items were generated and 30 items, with at least one per each theme, remained after importance analysis. Out of the 30 items, 23 (77%) refer to material conditions, 4 (13%) to psychological response and 3 (10%) to coping behaviors. Conclusions: The first results of the proFFiT project show that most of the items selected by patients are related to material conditions that cause, or derive from, financial hardship. The final questionnaire will be ready by the end of 2019. Supported by Fondazione AIRC IG grant 2017-20402. Clinical trial information: NCT03473379 .
Collapse
Affiliation(s)
- Jane Bryce
- Istituto Nazionale per lo Studio e la Cura dei Tumori, IRCCS Fondazione Pascale, Naples, Italy
| | - Silvia Riva
- University of Wolverhampton, Wolverhampton, United Kingdom
| | - Massimo Di Maio
- Department of Oncology, University of Turin, Ordine Mauriziano Hospital, Torino, Italy
| | | | - Luciano Frontini
- Federation of Italian Cooperative Oncology Groups (FICOG), Milan, Italy
| | - Ciro Gallo
- Università Della Campania "Luigi Vanvitelli", Naples, Italy
| | | | | | | | | | | | | | | | | | | | - Anna Gimigliano
- Istituto Nazionale per lo Studio e la Cura dei Tumori, IRCCS Fondazione Pascale, Naples, Italy
| | - Lucia Sparavigna
- Istituto Nazionale per lo Studio e la Cura dei Tumori, IRCCS Fondazione Pascale, Naples, Italy
| | - Francesco Perrone
- Istituto Nazionale per lo Studio e la Cura dei Tumori, IRCCS Fondazione Pascale, Naples, Italy
| |
Collapse
|
4
|
Riva S, Caminiti C, Iannelli E, Bryce J, Bagnalasta M, Arpinelli F, Bassi M, Betteto P, Del Mastro L, De Persis D, Nicelli A, Passalacqua R, Porta C, Sparavigna L, Diodati F, Piparo C, Novello S, Castro K, Mitchell S, Perrone F. Cross-cultural adaptation of the US National Cancer Institute's PRO-CTCAE instrument into Italian for adult cancer patients. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw345.08] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
5
|
Ruggiero R, Docimo G, Russo V, Sparavigna L, Verde I, Capuano P, Topatino A, Gili S, Amoroso V, Mozzillo AL, Iovinella E, D'Anna R, Bosco A, Docimo L. [Bilio-intestinal bypass in the treatment of metabolic syndrome in obese patient]. G Chir 2010; 31:527-533. [PMID: 21232198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
INTRODUCTION obesity (O) is a chronic patologic condition, evolutive and relapsing, with multifactorial etiopathogenesis, consisting in an alteration of the body's composition characterized by a relative and absolute excess of fat, that gets worse the life quality and causes complications that can lead to death. PATIENTS AND METHODS experience concerns twenty-five diabetic obese patients underwent bilio-intestinal by-pass between January 2006-December 2007. All these patients, before the surgical operation, underwent a rigorous clinical and laboratory examination. Besides, a precise rate control of laboratory, overlap with those performed in the pre-operative period of operation, was required for each patient: the first after one month, the second after six months and the third after twelve months. RESULTS the average weight loss was about 40 kg and, more important, these data show that the BMI is reduced, until to become stable, after 12 months from surgical operation, about values 34-31 Kg/m², obtaining, in this way, an improvement of values in the development metabolic syndrome and, above all, heart rate and ventricular repolarization. CONCLUSIONS the data obtained by our study support the hypothesis to suggest the operations of bariatric malassorbing surgery, in particular bilio-intestinal by-pass, as prophylactic methods for dismetabolics diseases, with reduction of cardiovascular risk in obese patient.
Collapse
Affiliation(s)
- R Ruggiero
- Seconda Università Degli Studi di Napoli
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Ruggiero R, Procaccini E, Gili S, Cremone C, Parmeggiani D, Conzo G, Docimo L, Sparavigna L, Gubitosi A, Docimo G, Sanguinetti A, Avenia N. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. G Chir 2009; 30:306-310. [PMID: 19580713] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
BACKGROUND Axillary lymphadenectomy remains an integral part of breast cancer treatment, yet seroma formation occurs in 15-85% of cases. Among methods to reduce seroma magnitude and duration, fibrin glue has been proposed in several studies with controversial results. PATIENTS AND METHODS Ninety patients underwent quadrantectomy or mastectomy with level I/II axillary lymphadenectomy; a suction drain was fitted in all patients. Fibrin glue spray were applied to the axillary fossa in 45 patients; the other 45 patients were treated conventionally. RESULTS Suction drainage was removed between post-operative (p.o.) days 3 and 4. Seroma magnitude and duration were significantly reduced (p 0.004 and 0.02, respectively), and there were fewer evacuative punctures, in patients receiving fibrin glue compared with the conventional treatment group. CONCLUSIONS Use of fibrin glue does not always prevent seroma formation, but does reduce seroma magnitude, duration and evacuative punctures.
Collapse
Affiliation(s)
- R Ruggiero
- General and Specialistic Surgery, Second University of Naples
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Ruggiero R, Procaccini E, Sanguinetti A, Cremone C, Gili S, Docimo G, Docimo L, Sparavigna L, Gubitosi A, Parmeggiani D, Avenia N. Ductal carcinoma in situ of the breast: our experience. G Chir 2009; 30:121-124. [PMID: 19351465] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
AIM The ductal carcinoma in situ (DCIS) is a more and more frequent neoplasia, representing over 25% of diagnosed breast cancer in recent surveys.It is particularly interesting as concerns several aspects of which the most important are issues linked to clinical diagnosis and the difficulties of histopathological classification, with evident and important therapeutic implications. PATIENTS AND METHODS The authors report their experience about 161 ductal carcinoma in situ of the breast. Guidelines for surgical treatment are: radiological or clinical diagnosis, tumor's extension, histological classification, grading and margin status. At the present the authors prefer breast conserving surgery with tumor margin's study. They report their experience in the last seven years about sentinel lymph node biopsy. RESULTS The most frequent histotype resulted comedocarcinoma (61,8%) followed by non comedo (38,2%). Local recurrence after DCIS therapy is 6,1%. CONCLUSIONS 80-90% of the patients currently treated for DCIS present non-palpable breast lesions at diagnosis. Breast conserving surgery is the first choice and radiotherapy and endocrine therapy are indicated for selected patients.
Collapse
MESH Headings
- Adult
- Aged
- Antineoplastic Agents, Hormonal/therapeutic use
- Breast Neoplasms/diagnosis
- Breast Neoplasms/pathology
- Breast Neoplasms/surgery
- Breast Neoplasms/therapy
- Carcinoma, Intraductal, Noninfiltrating/diagnosis
- Carcinoma, Intraductal, Noninfiltrating/pathology
- Carcinoma, Intraductal, Noninfiltrating/surgery
- Carcinoma, Intraductal, Noninfiltrating/therapy
- Chemotherapy, Adjuvant
- Female
- Follow-Up Studies
- Humans
- Mastectomy, Segmental/methods
- Middle Aged
- Neoplasm Recurrence, Local/diagnosis
- Neoplasm Recurrence, Local/prevention & control
- Practice Guidelines as Topic
- Radiotherapy, Adjuvant
- Retrospective Studies
- Sentinel Lymph Node Biopsy
- Treatment Outcome
Collapse
Affiliation(s)
- R Ruggiero
- Department of General and Specialistic Surgery, Second University of Naples, Italy
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Gubitosi A, Moccia G, Malinconico FA, Docimo G, Ruggiero R, Iside G, Avenia N, Docimo L, Foroni F, Gilio F, Sparavigna L, Agresti M. [Conservative anal fistula treatment with collagenic plug and human fibrin sealant. Preliminary results]. G Chir 2009; 30:46-50. [PMID: 19272233] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
The authors, on the basis of a long clinical experience with human fibrin glue in general surgery, compared two different extracellular matrix (collagen), Surgisis and TissueDura, with human fibrin glue, applied during the operation, and sometimes in postoperative, to obtain the healing of perianal fistulas. The collagenic extracellular matrix provides, according to the rationale suggested, an optimal three-dimensional structure for the fibroblastic implant and neoangiogenesis, hence for the fistula "fibrotizzation" and closure. The encouraging results for transphincteric fistulas and a simple and easy technique push to researchers on samples statistically significant.
Collapse
Affiliation(s)
- A Gubitosi
- Seconda Università degli Studi di Napoli, Azienda Ospedaliera Universitaria, DAI di Chirurgia Generale e dei Trapianti
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Docimo G, Avenia N, Ragusa M, Gili S, Parmeggiani D, Casalino G, Gubitosi A, Procaccini E, Ruggiero R, Sparavigna L, Docimo L. [Non recurrent inferior laryngeal nerve: our surgical experience]. Clin Ter 2009; 160:347-349. [PMID: 19997678] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
AIM Iatrogenic damage to the recurrent laringeal nerve is the most feared complication in thyroid surgery and the main cause for vocal cord palsy. Prevention of such a lesion is based upon the thorough search for the nerve along its anatomic pathway. In the present study the Authors discuss an important anatomic variation: non-recurrent inferior laryngeal nerve, emphasizing the aspects of surgical anatomy, on the basis of their own experience in neck surgery. MATERIALS AND METHODS The study takes into conideration 301 surgical interventions on the thyroid gland, in 268 women and 33 men; consisting in 256 total thyroidectomies and 45 loboisthmectomies, as follows: 186 for nodular goiter, 48 for follicular nodule, 34 for papillifer carcinoma, 33 for toxic goiter. The identification and exposure of inferior laryngeal nerve was performed according to the principles and technique by Lahey. RESULTS The overall prevalence of non recurrent inferior laryngeal nerve was equal to 0.33% (1/301 operations). The anomaly is prevailing on the right side, being due by an anomalous reabsorption of the IV ventral arch. This is the cause of the formation of a subclavian artery that is responsible for dysphagia lusoria. CONCLUSIONS The rationale for the preservation of recurrent nerve is its systematic identification and exposure along all its course from its laryngeal entry. Diagnosis of non recurrent inferior laryngeal nerve is exclusively intra-operative. The anomaly is clinically asymptomatic and its suspicion can be posed in case of vascular anomalies or dysphagia. In such a circumstance the golden diagnostic tool is the angio Tc-RMN, while both the EGDS and baritate esophagous can be of some diagnostic help.
Collapse
Affiliation(s)
- G Docimo
- Dipartimento Assistenziale Integrato di Chirurgia Generale e Specialistica, Seconda Università di Napoli, Italia.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Ruggiero R, Procaccini E, Cuccurullo V, Mansi L, Gili S, Cremone C, Docimo G, Docimo L, Sparavigna L, Gubitosi A, Iovino F, Parmeggiani D, Avenia N. Plurifocal breast cancer and double lymphatic spread. G Chir 2008; 29:424-426. [PMID: 18947466] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
BACKGROUND Sentinel node (SN) has been proved to be a reliable technique in predicting the lymph nodes state of the axilla in breast cancer. For the majority of the authors the intradermal and peritumoral injection is the best way. PATIENTS AND METHODS Our experience, from 1997, includes 587 cases of SN in women with resectable breast cancer less than 3 cm of diameter. We performed the lymphoscintigraphy after a peritumoral injection of radioactive tracer and, if the lesion was superficial, we associated an intradermal injection on the skin above the lesion itself. Two patients had multifocal right breast cancer. We did two separate injections around each tumor. RESULTS The radioactive tracer spread towards the internal mammary chain and homolateral axillary nodes. CONCLUSIONS We consider the peritumoral injection as essential in tumors located deeply in the breast (under ultrasound guide if not palpable) together with intradermal injection in superficial ones. Using this technique the possibility of a mis-identification of the SN is reduced.
Collapse
Affiliation(s)
- R Ruggiero
- Second University of Naples, Department of General and Specialistic Surgery, Naples
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Ruggiero R, Procaccini E, Gili S, Cremone C, Docimo G, Iovino F, Docimo L, Sparavigna L, Gubitosi A, Parmeggiani D, Avenia N. Fibrin glue to reduce seroma after axillary lymphadenectomy for breast cancer. MINERVA CHIR 2008; 63:249-254. [PMID: 18577912] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
UNLABELLED Axillary lymphadenectomy remains an integral part of breast cancer treatment, yet seroma formation occurs in 15-85% of cases. Among the methods employed to reduce seroma magnitude and duration, fibrin glue has been proposed in numerous studies with controversial RESULTS Sixty patients underwent quadrantectomy or mastectomy with level I/II axillary lymphadenectomy; a suction drain was fitted in all patients. Fibrin glue spray was applied to the axillary fossa in 30 patients; the other 30 patients were treated conventionally. Suction drainage was removed between postoperative days III and IV. Seroma magnitude and duration were significantly reduced (P=0.004 and 0.02, respectively), and there were fewer evacuative punctures, in patients receiving fibrin glue compared with the conventional treatment group. The authors conclude that the use of fibrin glue does not always prevent seroma formation, but does reduce seroma magnitude, duration and necessary evacuative punctures.
Collapse
Affiliation(s)
- R Ruggiero
- General and Specialistic Surgery, Second University of Naples, Naples, Italy.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Docimo G, Manzi F, Maione L, Canero A, Veneto F, Lo Schiavo F, Sparavigna L, Amoroso V, De Rosa M, Docimo L. Case report: laparoscopic cholecystectomy in situs viscerum inversus. Hepatogastroenterology 2004; 51:958-60. [PMID: 15239223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/30/2023]
Abstract
Situs viscerum inversus is a rare condition, in which the organs are transposed from their normal location in the opposite side of the body. The inversion of L-R asymmetry may be complete (SVI totalis) or partial (SVI partialis), whereby transposition is confined to either the abdominal or thoracic viscera. The authors report a case of videolaparocholecystectomy for cholelithiasis successfully performed on a 41-year-old Caucasian woman with situs viscerum inversus totalis. The patient was discharged on the 2nd postoperative day. The symptomatology disappeared right after the intervention, and still now, after a follow-up of six months, is absent. The procedure was safely performed on the patient with no particular difficulties, except for the reverse position of the angle between the operating and exposing trocars, which led to a difficult approach to the Calot triangle when using the right hand of the surgeon.
Collapse
Affiliation(s)
- G Docimo
- III Divisione di Chirurgia Generale e Oncologica, Seconda Universita' di Napoli, Napoli, Italia.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Cennamo A, Tolomeo R, Sparavigna L, Izzo A. [Meckel's diverticulum. Our experience]. MINERVA CHIR 2000; 55:319-24. [PMID: 10953566] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/17/2023]
Abstract
BACKGROUND The paper aimed to highlight the percentage presence of Meckel's diverticulum compared to appendiceal pathology in a retrospective study and whether its surgical removal is always useful, even if asymptomatic. METHODS The study was performed at the Institute of Emergency Surgery at the Second University of Naples (Head: Prof. R. Docimo) in 1211 patients affected by appendiceal-like pathology, reported to the authors' attention for both elective and emergency surgery from 1973 to today. The presence of Meckel's diverticulum was rarely diagnosed in preoperative patients; it was occasionally found in both elective surgery in patients with other abdominal pathologies, above all appendicitis, and in patients undergoing emergency surgery for acute pathologies (occlusion, peritonitis) caused by the former. The diverticulum was always totally removed (diverticulectomy or intestinal resection) even when it was asymptomatic. RESULTS The results were satisfactory in all patients and at the one-year follow-up none complained of discomfort. CONCLUSIONS We are convinced that Meckel's diverticulum should be investigated as a matter of course during appendectomy and, where present, it should be removed even if asymptomatic because the problems arising secondary to complications are undoubtedly more severe compared to any discomfort following its surgical removal.
Collapse
Affiliation(s)
- A Cennamo
- Istituto di Clinica Chirurgica Generale e Chirurgia d'Urgenza e Pronto Soccorso, II Università degli Studi, Napoli
| | | | | | | |
Collapse
|
14
|
Cennamo A, Tolomeo R, Falsetto A, Sparavigna L, Menduni Dè Rossi A. [Evolution of the surgical treatment of rectal cancer. Our experience]. Ann Ital Chir 2000; 71:227-32. [PMID: 10920495] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/17/2023]
Abstract
In this study we have reviewed our data from 1973 to 1998 and we have compared three intervals. In each of these periods we have performed the same type of surgery which enables the comparison of adopted techniques with obtained results. During the first period (1973-1980) we have treated 65 cases of rectum cancer staging between B2 and D, which were mainly localised in the medium rectum (41.2%). During the second period (1981-1990) we have treated 44 cases with a majority of patients staging B2. The localisation was again mainly in the medium rectum (38.5%). During the third period (1981-1998) we have treated 37 cases of rectum cancer staging between A2 and B1. Again the most frequent site was the medium rectum (48.9%). Consequently, we compared the staging, the type of surgery and the complications for the three periods. Our results show that the survival time was 5 years, in 70% of the cases where an anterior resection was performed, but this percentage decreased substantially if we also considered patients presenting with an advanced staging (C2-D), in which the only type of surgery that could be performed was colostomy or the simple explorative laparotomy.
Collapse
Affiliation(s)
- A Cennamo
- Istituto di Clinica Chirurgica Generale e Chirurgia D'Urgenza, Facoltà di Medicina e Chirurgia, Seconda Università degli Studi di Napoli
| | | | | | | | | |
Collapse
|